News
Catch up on our latest updates
Innovation is one of the pillars of Eclipsebio’s culture, and our team of RNA experts is always developing new technologies and solutions. Learn more about our latest breakthroughs below.
2026 RNA Trailblazers Award
The RNA Trailblazers Award helps offset the cost of RNA biology experiments for undergraduate and graduate student researchers.
Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™
eSTRAND RNA QC uses direct RNA sequencing to provide multiple critical quality attributes in a single run without requiring reverse transcription or translation.
Wacker Biotech and Eclipsebio Announce Strategic Collaboration to Advance RNA Medicine Development and Production
The collaboration will combine Wacker Biotech's large-scale, GMP-compliant manufacturing with Eclipsebio's AI-driven RNA design and sequencing-based characterization for best-in-class end-to-end RNA therapeutic development support.
RNA Delivery Prato 2026
Eclipsebio is proud to sponsor the 2026 RNA Delivery Prato meeting to discuss recent discoveries and challenges in RNA delivery.
Eclipsebio Expands eCOMPASS™ Platform with eSENSE Break™ to Map RNA Fragmentation at Nucleotide Resolution
Eclipsebio's eSENSE Break uses sequencing-based analytics to map RNA fragmentation and circular RNA nicking sites at single-nucleotide resolution.
2026 Data Catalyst Award Call for Applications
The Data Catalyst Award helps offset the cost of RNA profiling experiments using Eclipsebio's assays from our RNA profiling portfolio and contributes to the eVERSE database.